Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

The Canadian Bioceutical CBICF

MPX Bioceutical Corp is a Canada based company involved in the natural health products industry. It is engaged in the manufacture and distribution of nutraceuticals to the North American marketplace and providing financial and business expertise to emerging corporations primarily in the pharmaceutical, medical and biotechnology industries. The company provides management, staffing, procurement, advisory, financial, real estate rental, logistics and administrative services to two medicinal cannab


GREY:CBICF - Post by User

Comment by OnVacationon Aug 05, 2018 11:31am
168 Views
Post# 28416211

RE:RE:MPX Bioceutical over-performed Organigram in Revenue in sale

RE:RE:MPX Bioceutical over-performed Organigram in Revenue in saleHey Bluesguy, if you don’t own either stock what are you doing on here posting comments.  Leave bogdansz’s posts alone.  MPX is a great company that in time will reward us loyal holders. In the mean time positive, truthful posts are appreciated and encouraged on the board.  
Bluesguy wrote:
bogdansz wrote: Organigram Holdings within the three month period the company was able to produce only $3.7 million dollars in sales only half what MPX Bioceuticals did and Organigram is trading at $ 5 per share currently


Well of course...because they aren't bleeding red ink to the tune of $18M ! MPX rev is a great indictor of forward profits but until they get out of the hole they will not get anywhere close to OGI. OGI deserves the multiple because they are delivering to their shareholders NOW and rec hasn't even started yet. Disclaimer ...I have position in either stock.


<< Previous
Bullboard Posts
Next >>